CMPX

Compass Therapeutics
CMPX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$251.67M
EV
$145.42M
Shares Outstanding
138.28M
Beta
1.19

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$13.10
P/E 2025E
-
P/Revenue 2025E
180.44x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Compass Therapeutics, Inc.

gainify
CMPX

Compass Therapeutics, Inc.

CMPX

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. The company’s lead product candidates include CTX-009, a bispecific antibod...

Sector

Healthcare

Industry

Biotechnology

CEO

Schuetz, Thomas

Employees

35

IPO Date

2021-04-05

Headquarters

80 Guest Street, Suite 601, Boston, Massachusetts, 02135, United States

gainify
mailcontactcontact
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.